Related Experiment Video
Updated: Apr 29, 2026

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
Published on: December 26, 2015
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation
Franca Tecchio1, Andrea Cancelli, Carlo Cottone
1Laboratory of Electrophysiology for Translational neuroScience (LET'S)-ISTC-CNR, Department of Clinical Neuroscience, Fatebenefratelli Hospital, Isola Tiberina, 00186, Rome, Italy, franca.tecchio@istc.cnr.it.
Anodal transcranial direct current stimulation (tDCS) significantly reduced multiple sclerosis fatigue in a small study. This non-pharmacological approach offers potential relief for patients struggling with debilitating fatigue.
Area of Science:
- Neuroscience
- Neurology
- Rehabilitation Medicine
Background:
- Multiple sclerosis (MS)-related fatigue is a prevalent and often treatment-resistant symptom.
- Fatigue significantly impairs the quality of life for individuals with MS.
Purpose of the Study:
- To investigate the efficacy of anodal bilateral primary somatosensory areas transcranial direct current stimulation (tDCS) for treating MS-related fatigue.
- To assess the impact of personalized neuromodulation on fatigue severity in MS patients.
Main Methods:
- A randomized, double-blind, sham-controlled, cross-over study involving ten fatigued MS patients.
- Application of two blocks of 5-day anodal bilateral primary somatosensory areas tDCS using personalized electrodes.
- Fatigue levels were assessed before and after real and sham stimulation.
Main Results:
- Real anodal tDCS significantly reduced fatigue by an average of 26% (p = 0.002).
- No significant change in fatigue was observed after sham stimulation (p = 0.901).
- All patients receiving real tDCS experienced fatigue relief.
Conclusions:
- Anodal tDCS over bilateral somatosensory areas is an effective non-pharmacological treatment for multiple sclerosis fatigue.
- This neuromodulation technique shows promise for improving the quality of life in mildly disabled MS patients experiencing severe fatigue.
- Modulating sensorimotor network activity may be a viable therapeutic strategy for MS fatigue.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Somatosensation

